239 related articles for article (PubMed ID: 1358641)
1. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
3. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.
Mao J; Price DD; Mayer DJ
J Neurosci; 1994 Apr; 14(4):2301-12. PubMed ID: 7908958
[TBL] [Abstract][Full Text] [Related]
4. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation.
Ho J; Mannes AJ; Dubner R; Caudle RM
J Pharmacol Exp Ther; 1997 Apr; 281(1):136-41. PubMed ID: 9103490
[TBL] [Abstract][Full Text] [Related]
5. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1994 Feb; 268(2):701-8. PubMed ID: 8113981
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats.
Okano K; Kuraishi Y; Satoh M
Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400
[TBL] [Abstract][Full Text] [Related]
7. Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse.
Suh H; Song D; Huh S; Kim YH
Brain Res Bull; 2000 May; 52(2):143-50. PubMed ID: 10808085
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice.
Näsström J; Karlsson U; Post C
Eur J Pharmacol; 1992 Feb; 212(1):21-9. PubMed ID: 1313371
[TBL] [Abstract][Full Text] [Related]
9. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats.
Hama A; Woon Lee J; Sagen J
Eur J Pharmacol; 2003 Jan; 459(1):49-58. PubMed ID: 12505533
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
12. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.
Mao J; Price DD; Hayes RL; Lu J; Mayer DJ
Brain Res; 1992 Dec; 598(1-2):271-8. PubMed ID: 1362520
[TBL] [Abstract][Full Text] [Related]
14. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
15. Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in rats.
Zhang YQ; Ji GC; Wu GC; Zhao ZQ
Pain; 2002 Oct; 99(3):525-535. PubMed ID: 12406529
[TBL] [Abstract][Full Text] [Related]
16. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.
Eisenach JC; Gebhart GF
Anesthesiology; 1995 Nov; 83(5):1046-54. PubMed ID: 7486155
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint.
Neugebauer V; Lücke T; Schaible HG
J Neurophysiol; 1993 Oct; 70(4):1365-77. PubMed ID: 7904298
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Effects of L-4-Chlorokynurenine on Nociception in Rodents.
Yaksh TL; Schwarcz R; Snodgrass HR
J Pain; 2017 Oct; 18(10):1184-1196. PubMed ID: 28428091
[TBL] [Abstract][Full Text] [Related]
20. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
